EGFR and colorectal neoplasm: In contrast, mice harboring larger colorectal tumors (score 4–5) displayed significantly reduced splenic PD-1 expression exclusively after anti-EGFR Ab treatment under a GFHPD, while no differences were observed under a CD (Figure 6n).